Role of CD4+CD25high+FOXP3+ regulatory T cells in psoriasis

Annals of Dermatology

Volumn 22, Issue 4, 2010, Pages 397-403

  Yun, Woo Jin ^a   Lee, Deok Woo ^b   Chang, Sung Eun ^b   Yoon, Ghil Suk ^c   Huh, Joo Ryung ^b   Won, Chong Hyun ^b   Lee, Mi Woo ^b   Kim, Sung Eun ^d   Kim, Beom Joon ^d   Moon, Kee Chan ^b   Choi, Jee Ho ^b  

^a Cleanup Dermatology Clinic   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d Chung Ang University   (South Korea)

Author keywords

Cd4+cd25high+regulatory t cells; FOXP3; Psoriasis

Indexed keywords

EID: 79955571636     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2010.22.4.397     Document Type: Article

References (19)

1. Read S, Malmström V, Powrie F. Cytotoxic T lymphocyteassociated antigen 4 plays an essential role in the function of CD25 (+) CD4 (+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302. (Pubitemid 30470312)
2. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25 (+) CD4 (+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3:135-142. (Pubitemid 34141443)
3. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, etal. CD4 (+) CD25 (+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-323.
4. Lehmann J, Huehn J, de la Rosa M, Maszyna F, Kretschmer U, Krenn V, et al. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25-regulatory T cells. Proc Natl Acad Sci U S A 2002;99: 13031-13036.
5. Liu H, Leung BP. CD4 + CD25+ regulatory T cells in health and disease. Clin Exp Pharmacol Physiol 2006;33:519-524.
6. Taams L, Vukmanovic-Stejic M, Salmon M, Akbar A. Immune regulation by CD4 + CD25+ regulatory T cells: implications for transplantation tolerance. Transpl Immunol 2003;11:277-285.
7. Mutis T, Aarts-Riemens T, Verdonck LF. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions. Haematologica 2005;90:1389-1395. (Pubitemid 41503655)
8. Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, et al. Reduced frequency of FOXP3+ CD4 + CD25 + regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005;106:2903-2911.
9. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169:2756-2761.
10. Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL, et al. Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002;168:4272-4276.
11. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006;6:295-307.
12. Kagen MH, McCormick TS, Cooper KD. Regulatory T cells in psoriasis. Ernst Schering Res Found Workshop 2006:193-209.
13. Veldman C, Nagel A, Hertl M. Type I regulatory T cells in autoimmunity and inflammatory diseases. Int Arch Allergy Immunol 2006;140:174-183. (Pubitemid 43725813)
14. Chattopadhyay S, Mehrotra S, Chhabra A, Hegde U, Mukherji B, Chakraborty NG. Effect of CD4 + CD25+ and CD4 + CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumorassociated epitope in vitro. J Immunol 2006;176:984-990.
15. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886.
16. Zheng SG, Wang JH, Stohl W, Kim KS, Gray JD, Horwitz DA. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4 + CD25 + regulatory cells. J Immunol 2006;176:3321-3329.
17. Vissers WH, Arndtz CH, Muys L, Van Erp PE, de Jong EM, van de Kerkhof PC. Memory effector (CD45RO +) and cytotoxic (CD8 +) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol 2004;150:852-859.
18. Sugiyama H, Gyulai R, Toichi E, Garaczi E, Shimada S, Stevens SR, et al. Dysfunctional blood and target tissue CD4 + CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005;174:164-173.
19. Bovenschen HJ, van Vlijmen-Willems IM, van de Kerkhof PC, van Erp PE. Identification of lesionai CD4+ CD25 + Foxp3 + regulatory T cells in Psoriasis. Dermatology 2006; 213:111-117.